Publications

  1. Hasin T, Kushwaha SS, Lesnick TG, Kremers W, Boilson BA, Schirger JA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Jaffe AS. Early trends in N-terminal pro-brain natriuretic Peptide values after left ventricular assist device implantation for chronic heart failure. Am J Cardiol. 2014 Oct 15; 114(8):1257-63. Epub 2014 Aug 01.
    View PubMed
  2. Kavsak PA, Jaffe AS, Hickman PE, Mills NL, Humphries KH, McRae A, Devereaux PJ, Lamy A, Whitlock R, Dhesy-Thind SK, Potter JM, Worster A. Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. Clin Biochem. 2014 Oct 07.
    View PubMed
  3. Karon BS, Tolan NV, Koch CD, Wockenfus AM, Miller RS, Lingineni RK, Pruthi RK, Chen D, Jaffe AS. Precision and Reliability of 5 Platelet Function Tests in Healthy Volunteers and Donors on Daily Antiplatelet Agent Therapy. Clin Chem. 2014 Oct 03.
    View PubMed
  4. Apple FS, Hollander J, Wu AH, Jaffe AS. Improving the 510(k) FDA Process for Cardiac Troponin Assays: In Search of Common Ground. Clin Chem. 2014 Oct; 60(10):1273-5. Epub 2014 Aug 11.
    View PubMed
  5. Sara JD, Holmes DR Jr, Jaffe AS. Fundamental Concepts of Effective Troponin Use- Important Principles For Internists. Am J Med. 2014 Sep 15.
    View PubMed
  6. Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, Hollander J, Plebani M, Than M, Chan MH, on behalf of the International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2014 Sep 07.
    View PubMed
  7. McKie PM, AbouEzzeddine OF, Scott CG, Mehta R, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic Peptide predict heart failure and mortality in the general population. Clin Chem. 2014 Sep; 60(9):1225-33. Epub 2014 Jul 01.
    View PubMed
  8. White HD, Thygesen K, Alpert JS, Jaffe AS. Republished: Clinical implications of the Third Universal Definition of Myocardial Infarction. Postgrad Med J. 2014 Sep; 90(1067):502-10.
    View PubMed
  9. Biener M, Mueller M, Vafaie M, Jaffe AS, Katus HA, Giannitsis E. Prognostic performance of high-sensitivity cardiac troponin T kinetic changes adjusted for elevated admission values and the GRACE score in an unselected emergency department population. Clin Chim Acta. 2014 Aug 5; 435:29-35. Epub 2014 Apr 26.
    View PubMed
  10. Herrmann J, Lennon RJ, Jaffe AS, Holmes DR Jr, Rihal CS, Prasad A. Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention. Circ Cardiovasc Interv. 2014 Aug; 7(4):533-42. Epub 2014 Jul 22.
    View PubMed
  11. Lin DC, Diamandis EP, Januzzi JL Jr, Maisel A, Jaffe AS, Clerico A. Natriuretic peptides in heart failure. Clin Chem. 2014 Aug; 60(8):1040-6. Epub 2014 Apr 03.
    View PubMed
  12. Jaffe AS, Moeckel M, Giannitsis E, Huber K, Mair J, Mueller C, Plebani M, Thygesen K, Lindahl B. In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2014 Jul 09.
    View PubMed
  13. Vasile VC, Jaffe AS. Emerging biomarkers for acute heart conditions. Curr Opin Cardiol. 2014 Jul; 29(4):312-8.
    View PubMed
  14. Apple FS, Jaffe AS. Men are different than women: It's true for cardiac troponin too. Clin Biochem. 2014 Jul; 47(10-11):867-8. Epub 2014 Jun 11.
    View PubMed
  15. Carney RM, Steinmeyer B, Freedland KE, Stein PK, Hayano J, Blumenthal JA, Jaffe AS. Nocturnal patterns of heart rate and the risk of mortality after acute myocardial infarction. Am Heart J. 2014 Jul; 168(1):117-25. Epub 2014 Apr 27.
    View PubMed
  16. Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol. 2014 May 20; 63(19):2016-25. Epub 2014 Mar 26.
    View PubMed
  17. Defilippis AP, Rai SN, Cambon A, Miles RJ, Jaffe AS, Moser AB, Jones RO, Bolli R, Schulman SP. Fatty acids and TxA2 generation, in the absence of platelet-COX-1 activity. Nutr Metab Cardiovasc Dis. 2014 Apr; 24(4):428-33. Epub 2013 Oct 23.
    View PubMed
  18. Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, Beeri R, Weissman C, Sprung CL, Landesberg A. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014 Apr; 42(4):790-800.
    View PubMed
  19. Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, Grogan M, Zeldenrust SR, Hayman SR, Buadi F, Greipp PR, Leung N, Russell SR, Dingli D, Lust JA, Rajkumar SV, Jaffe AS. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014 Mar; 100(5):383-8. Epub 2014 Jan 08.
    View PubMed
  20. Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014 Feb; 127(2):105-8. Epub 2013 Oct 16.
    View PubMed
  21. Schulz O, Postnikov AB, Smolyanova TI, Katrukha AG, Schimke I, Jaffe AS. Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease. Clin Biochem. 2014 Feb; 47(3):177-83. Epub 2013 Nov 05.
    View PubMed
  22. Mair J, Jaffe AS. Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? Mol Diagn Ther. 2014 Feb; 18(1):5-15.
    View PubMed
  23. Korley FK, Schulman SP, Sokoll LJ, Defilippis AP, Stolbach AI, Bayram JD, Saheed MO, Omron R, Fernandez C, Lwin A, Cai SS, Post WS, Jaffe AS. Troponin elevations only detected with a high-sensitivity assay: Clinical correlations and prognostic significance. Acad Emerg Med. 2014; 21(7):728-35.
  24. White HD, Thygesen K, Alpert JS, Jaffe AS. Clinical implications of the third universal definition of myocardial infarction. Postgrad Med J. 2014; 90(1067):502-10.
  25. White HD, Thygesen K, Alpert JS, Jaffe AS. Clinical implications of the Third Universal Definition of Myocardial Infarction. Heart. 2014; 100(5):424-32.
  26. White H, Thygesen K, Alpert JS, Jaffe A. Universal MI definition update for cardiovascular disease. Curr Cardiol Rep. 2014; 16(6):492.
  27. Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS. Elevated cardiac troponin T levels in critically ill patients with sepsis. Am J Med. 2013 Dec; 126(12):1114-21. Epub 2013 Sep 28.
    View PubMed
  28. Koerbin G, Abhayaratna WP, Potter JM, Apple FS, Jaffe AS, Ravalico TH, Hickman PE. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem. 2013 Nov; 46(16-17):1636-43. Epub 2013 Aug 24.
    View PubMed
  29. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, Aldous S, Meller B, Tate JR, Reichlin T, Hammett CJ, Zellweger C, Ungerer JP, Rubini Gimenez M, Troughton R, Murray K, Brown AF, Mueller M, George P, Mosimann T, Flaws DF, Reiter M, Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013 Oct 1; 62(14):1242-9. Epub 2013 Apr 10
    View PubMed
  30. DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, Guallar E, Blumenthyal RS, Kickler TS, Jaffe AS, Gerstenblith G, Schulman SP, Rade JJ. Thromboxane A2 generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. Circ J. 2013 Oct; 62(14):1242-9.
  31. Schneider DJ, Avera ES, Bergmann SR, Braunwald E, Collen D, Frye R, Jaffe A, Kirk RJ, Ludbrook PA, Roberts R, Spector P, Vlasuk GP, Willerson JT. In memoriam: Burton E. Sobel a tribute from family, friends and colleagues October 21, 1937 - May 3, 2013. Exp Biol Med (Maywood). 2013 Oct; 238(10):1101-15.
    View PubMed
  32. Jaffe AS, Ordonez-Llanos J. High-sensitivity Cardiac Troponin: From Theory to Clinical Practice. Rev Esp Cardiol. 2013 Sep; 66(9):687-91. Epub 2013 Jul 16.
    View PubMed
  33. Jaffe AS, Ordonez-Llanos J. High-sensitivity Cardiac Troponin: From Theory to Clinical Practice. Rev Esp Cardiol (Engl Ed). 2013 Sep; 66(9):687-91. Epub 2013 Jul 16.
    View PubMed
  34. Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, Apple FS, Scott MG. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J. 2013 Aug; 166(2):325-332.e1. Epub 2013 Jun 24.
    View PubMed
  35. Hammarsten O, Jacobsson CE, Widegren M, Danylchenko T, Jaffe AS. Long-time quality assessment of the Elecsys Troponin T hs assay. Clin Biochem. 2013 Aug; 46(12):1055-7. Epub 2013 Apr 09.
    View PubMed
  36. Santalo M, Martin A, Velilla J, Povar J, Temboury F, Balaguer J, Munoz M, Calmarza P, Ortiz C, Carratala A, Gich I, Merce J, Jaffe AS, Ordonez-Llanos J. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med. 2013 Aug; 126(8):709-17. Epub 2013 Jun 10.
    View PubMed
  37. Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke G, Daniels LB, Hollander JE, Apple FS, Cannon C, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Stein JC, Headden G, Limkakeng AT Jr, Anand I, Wu AH, Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013 Jul 9; 62(2):150-60. Epub 2013 Apr 30.
    View PubMed
  38. McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013 Jul; 59(7):1099-107. Epub 2013 Apr 16.
    View PubMed
  39. Davidson KW, Bigger JT, Burg MM, Carney RM, Chaplin WF, Czajkowski S, Dornelas E, Duer-Hefele J, Frasure-Smith N, Freedland KE, Haas DC, Jaffe AS, Ladapo JA, Lesperance F, Medina V, Newman JD, Osorio GA, Parsons F, Schwartz JE, Shaffer JA, Shapiro PA, Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med. 2013 Jun 10; 173(11):997-1004.
    View PubMed
  40. Wu AH, Wians F, Jaffe A. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results. Am Heart J. 2013 Jun; 165(6):995-9. Epub 2013 Apr 06.
    View PubMed
  41. Liang JJ, Killu AM, Osborn MJ, Jaffe AS. Pacemaker lead perforation causing hemopericardium eight years after implantation. Indian Heart J. 2013 May-Jun; 65(3):331-3. Epub 2013 Apr 09.
    View PubMed
  42. Dunlay SM, Jaffe AS. Are biomarkers the answer to the heart failure readmissions problem? Clin Chem. 2013 May; 59(5):737-9. Epub 2013 Mar 07.
    View PubMed
  43. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol. 2013 Apr 30; 61(17):1753-8. Epub 2013 Feb 06.
    View PubMed
  44. Miller WL, Grill DE, Struck J, Jaffe AS. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure. Am J Cardiol. 2013 Mar 15; 111(6):880-5. Epub 2012 Dec 28.
    View PubMed
  45. Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, Cosio FG. Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival. Am J Transplant. 2013 Feb; 13(2):406-14. Epub 2012 Nov 08.
    View PubMed
  46. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, Lindahl B. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2013 Feb; 59(2):401-9. Epub 2012 Nov 09.
    View PubMed
  47. Jaffe AS. Third universal definition of myocardial infarction. Clin Biochem. 2013 Jan; 46(1-2):1-4. Epub 2012 Nov 02.
    View PubMed
  48. DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, Guallar E, Blumenthal RS, Kickler TS, Jaffe AS, Gerstenblith G, Schulman SP, Rade JJ. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. Circ J. 2013; 77(11):2786-92. Epub 2013 Aug 27.
    View PubMed
  49. Biener M, Mueller M, Vafaie M, Jaffe AS, Widera C, Katus HA, Giannitsis E. Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population. European Heart Journal: Acute Cardiovascular Care. 2013; 2(4):314-22.
  50. Olaf S, Debora B, Ricarda B, Gunnar B, Jochen K, Schimke I, Halle M, Jaffe A. Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fraction. Arch Med Sci. 2012 Dec 20; 8(6):1018-26. Epub 2012 Dec 19.
    View PubMed
  51. Sheldon SH, Crandall MA, Jaffe AS. Myocarditis with ST elevation and elevated cardiac enzymes misdiagnosed as an ST-elevation myocardial infarction. J Emerg Med. 2012 Dec; 43(6):996-9. Epub 2010 Dec 16.
    View PubMed
  52. Kaleta EJ, Jaffe AS, Baumann NA, Block DR. A case of floating gel. Clin Chem. 2012 Nov; 58(11):1604-5.
    View PubMed
  53. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Nat Rev Cardiol. 2012 Nov; 9(11):620-33. Epub 2012 Aug 25
    View PubMed
  54. Sheldon SH, Saenger AK, Jaffe AS. Incidence and significance of elevated lactate in the identification of critically ill patients. Clin Chem Lab Med. 2012 Oct 1; 50(10):1819-23.
    View PubMed
  55. Thygesen K Alpert JS Jaffe AS Simoons ML Chaitman BR White HD, the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third Universal Definition of Myocardial Infarction. Circulation. 2012 Oct; 126(16):2020-2035.
  56. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Mor Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2551-67. Epub 2012 Aug 24
    View PubMed
  57. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Mor Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2551-67. Epub 2012 Aug 24
    View PubMed
  58. Whang W, Burg MM, Carney RM, Freedland KE, Bigger JT, Catellier D, Czajkowski S, Frasure-Smith N, Haas DC, Jaffe AS, Lesperance F, Medina V, Duer-Hefele J, Osorio GA, Parsons F, Shapiro PA, Sheps DS, Vaccarino V, Davidson KW. Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. Contemp Clin Trials. 2012 Sep; 33(5):1003-10. Epub 2012 May 25.
    View PubMed
  59. Thygesen K Alpert JS Jaffe AS Simoons ML Chaitman R White HD, Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task FOrce for the universal definition of mocardial infarction. Third universal definition of myocardial infarction. JACC. 2012 Aug 29; 60(16):1581-1598.
  60. Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B, Koenig W, Tubaro M, Collinson P, Katus H, Galvani M, Venge P, Alpert JS, Hamm C, Jaffe AS, Study Group on Biomarkers in Cardiology of the ESC Workin Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012 Aug; 33(16):2001-6. Epub 2011 Feb 2
    View PubMed
  61. Dunlay SM, Weston SA, Killian JM, Bell MR, Jaffe AS, Roger VL. Thirty-day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med. 2012 Jul 3; 157(1):11-8.
    View PubMed
  62. Ayub B, Martinez MW, Jaffe AS, Couri DM. Giant saphenous vein graft pseudoaneurysm: treatment with a vascular occlusion device. Interact Cardiovasc Thorac Surg. 2012 Jul; 15(1):164-5. Epub 2012 Mar 28.
    View PubMed
  63. Koch CD, Wockenfus AM, Saenger AK, Jaffe AS, Karon BS. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. Clin Biochem. 2012 Jul; 45(10-11):842-4. Epub 2012 Apr 26.
    View PubMed
  64. Deo S, Greason KL, Gulati R, Jaffe AS, Holmes DR. Balloon aortic valvuloplasty under temporary mechanical circulatory support as a bridge to aortic valve replacement in a patient with hemodynamic failure secondary to critical aortic valve stenosis. Heart Surg Forum. 2012 Jun; 15(3):E177-9.
    View PubMed
  65. Jaffe AS. Troponin--past, present, and future. Curr Probl Cardiol. 2012 Jun; 37(6):209-28.
    View PubMed
  66. Miller WL, Grill DE, Jaffe AS. Comparison of novel pro-BNP(1-108) and standard BNP assays in heart failure patients. Clin Chim Acta. 2012 May 18; 413(9-10):920-6. Epub 2012 Feb 16.
    View PubMed
  67. Jaffe AS, Apple FS, Lindahl B, Mueller C, Katus HA. Why all the struggle about CK-MB and PCI? Eur Heart J. 2012 May; 33(9):1046-8. Epub 2012 Jan 11.
    View PubMed
  68. Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS, Sprung CL. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 2012 Apr; 33(7):895-903. Epub 2011 Sep 11
    View PubMed
  69. Gerber Y, Jaffe AS, Weston SA, Jiang R, Roger VL. Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience. Mayo Clin Proc. 2012 Mar; 87(3):247-54.
    View PubMed
  70. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J. 2012 Mar; 33(5):579-86. Epub 2012 Jan 19.
    View PubMed
  71. Miller WL, Hartman KA, Grill DE, Struck J, Bergmann A, Jaffe AS. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure. Heart. 2012 Mar; 98(5):389-94. Epub 2011 Dec 22.
    View PubMed
  72. Hess EP, Brison RJ, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Agarwal D, Sadosty AT, Silvilotti ML, Jaffe AS, Montori VM, Wells GA, Stiell IG. Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. Ann Emerg Med. 2012 Feb; 59(2):115-25.e1. Epub 2011 Sep 01.
    View PubMed
  73. Schmickl CN, Shahjehan K, Li G, Dhokarh R, Kashyap R, Janish C, Alsara A, Jaffe AS, Hubmayr RD, Gajic O. Decision support tool for early differential diagnosis of acute lung injury and cardiogenic pulmonary edema in medical critically ill patients. Chest. 2012 Jan; 141(1):43-50. Epub 2011 Oct 26.
    View PubMed
  74. Jaffe AS, Wu AH. Troponin release--reversible or irreversible injury? Should we care? Clin Chem. 2012 Jan; 58(1):148-50. Epub 2011 Oct 28.
    View PubMed
  75. Katus HA, Giannitsis E, Jaffe AS. Interpreting changes in troponin--clinical judgment is essential. Clin Chem. 2012 Jan; 58(1):39-43.
    View PubMed
  76. Pervaiz MA, Gau G, Jaffe AS, Saenger AK, Baudhuin L, Ellison J. A Non-classical Presentation of Tangier Disease with Three ABCA1 Mutations. JIMD Rep. 2012; 4:109-11. Epub 2011 Sep 28.
    View PubMed
  77. Sheldon SH, Crandall, Jaffe AS. Myocarditis with ST elevation and elevated cardiac enzymes misdiagnosed as an ST-elevation myocardial infarction. J Emer Med. 2012; 43(6):996-999.
  78. Thygesen K Mair J Giannitsis E Mueller C Lindahl B Blankenberg S Huber K Plebani M Biasucci LM Tubaro M Collinson P Venge P Hasin Y Galvani M Koenig W Hamm C Alpert JS Katus H Jaffe AS, The Study Group on Biomarkers in Cardiology of the ESC Working Group How to use high-sensitivity cardiac troponins in acute cardiac care. EHJ. 2012 Epub 2012 Jun 21.
  79. Eggers KM, Jaffe AS, Svennblad B, Lindahl B. A novel approach to cardiac troponins to improve the diagnostic work-up in chest pain patients. Critical Pathways in Cardiology. 2012; 11(4):199-205.
  80. Jaffe AS, Apple FS. The third universal definition of myocardial infarction - Moving forward. Clin Chem. 2012; 58(12):1727-8.
  81. Koerbin G, Potter JM, Abhayaratna WP, Telford RD, Badrick T, Apple FS, Jaffe AS, Hickman PE. Longitudinal studies of cardiac troponin I in a large cohort of healthy children. Clin Chem. 2012; 58(12):1665-72.
  82. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011 Oct 18; 58(17):1819-24. Epub 2011 Sep 29.
    View PubMed
  83. Oliver LK, Voskoboev N, Heser D, McConnell JP, Hodel-Hanson S, Callanan H, Jaffe AS. Assessment of clinical performance without adequate analytical validation: A prescription for confusion. Clin Biochem. 2011 Oct; 44(14-15):1247-52. Epub 2011 Jul 20.
    View PubMed
  84. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, Wibberley C, Nuttall M, Mackway-Jones K. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011 Sep 20; 58(13):1332-9.
    View PubMed
  85. Jaffe AS. The 10 commandments of troponin, with special reference to high sensitivity assays. Heart. 2011 Jun; 97(11):940-6.
    View PubMed
  86. Schulz O, Reinicke M, Kramer J, Berghofer G, Bensch R, Schimke I, Jaffe A. Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: use of a new monoclonal antibody-based assay. Clin Chim Acta. 2011 May 12; 412(11-12):880-6. Epub 2011 Jan 14.
    View PubMed
  87. Miller WL, Phelps MA, Wood CM, Schellenberger U, Van Le A, Perichon R, Jaffe AS. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail. 2011 May; 4(3):355-60. Epub 2011 Feb 03.
    View PubMed
  88. Arruda-Olson AM, Roger VL, Jaffe AS, Hodge DO, Gibbons RJ, Miller TD. Troponin T levels and infarct size by SPECT myocardial perfusion imaging. JACC Cardiovasc Imaging. 2011 May; 4(5):523-33.
    View PubMed
  89. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011 Apr 11; 412(9-10):748-54. Epub 2011 Jan 08.
    View PubMed
  90. Martinez MW, Rasmussen KG, Mueller PS, Jaffe AS. Troponin elevations after electroconvulsive therapy: the need for caution. Am J Med. 2011 Mar; 124(3):229-34.
    View PubMed
  91. Hallen J, Jensen JK, Buser P, Jaffe AS, Atar D. Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction. Acute Card Care. 2011 Mar; 13(1):48-51. Epub 2011 Jan 18.
    View PubMed
  92. Eggers KM, Jaffe AS, Venge P, Lindahl B. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. Clin Chim Acta. 2011 Jan 14; 412(1-2):91-7. Epub 2010 Sep 22.
    View PubMed
  93. Hallen J, Jensen JK, Fagerland MW, Jaffe AS, Atar D. Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2010 Dec; 96(23):1892-7.
    View PubMed
  94. Vasile VC, Chai HS, Khambatta S, Afessa B, Jaffe AS. Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. Am J Med. 2010 Nov; 123(11):1049-58.
    View PubMed
  95. Hallen J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D. Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus. Cardiovascular Diabetology. 2010 Sep 15; 9.
  96. Thygesen K, Johannes M, Katus H, Plebani M, Verge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller CH, Huber K, Hamm C, Jaffe AS. The Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Recommendations for the use of cardiac troponin measurement in acute cardiac care. EHJ. 2010 Sept; 31(18):2197-2204.
  97. Baudhuin LM, Miller WL, Train L, Bryant S, Hartman KA, Phelps M, Larock M, Jaffe AS. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure. Am J Cardiol. 2010 Aug 1; 106(3):402-8.
    View PubMed
  98. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010 Jul; 56(7):1086-90. Epub 2010 May 14.
    View PubMed
  99. Jaffe AS, Apple FS. In reply. Clin Chem. 2010 Jul; 56(7):1199-200. Epub 2010 May 20.
    View PubMed
  100. Schulz O, Reinicke M, Berghoefer GH, Bensch R, Kraemer J, Schimke I, Jaffe AS. High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray. Clin Chim Acta. 2010 Jun 3; 411(11-12):812-7. Epub 2010 Feb 24.
    View PubMed
  101. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem. 2010 Jun; 56(6):941-3. Epub 2010 Apr 01.
    View PubMed
  102. Arruda-Olson AM, Enriquez-Sarano M, Bursi F, Weston SA, Jaffe AS, Killian JM, Roger VL. Left ventricular function and C-reactive protein levels in acute myocardial infarction. Am J Cardiol. 2010 Apr 1; 105(7):917-21.
    View PubMed
  103. Kavsak PA, Worster A, You JJ, Oremus M, Elsharif A, Hill SA, Devereaux PJ, MacRae AR, Jaffe AS. Identification of myocardial injury in the emergency setting. Clin Biochem. 2010 Apr; 43(6):539-44. Epub 2009 Dec 21.
    View PubMed
  104. Hess EP, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Body R, Jaffe A, Wells GA, Stiell IG. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome. Acad Emerg Med. 2010 Apr; 17(4):368-75.
    View PubMed
  105. Jaffe AS, Apple FS. High-sensitivity cardiac troponin: hype, help, and reality. Clin Chem. 2010 Mar; 56(3):342-4. Epub 2009 Dec 29.
    View PubMed
  106. Kavsak PA, Newman AM, Ko DT, Macrae AR, Jaffe AS. The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department. Clin Biochem. 2010 Mar; 43(4-5):505-7. Epub 2009 Nov 10.
    View PubMed
  107. Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J, Yawn BP, Jacobsen SJ. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010 Feb 23; 121(7):863-9. Epub 2010 Feb 08.
    View PubMed
  108. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010 Feb; 56(2):254-61. Epub 2009 Dec 03.
    View PubMed
  109. Cullen L, Than M, Brown AF, Richards M, Parsonage W, Flaws D, Hollander JE, Christenson RH, Kline JA, Goodacre S, Jaffe AS. Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia. Emerg Med Australas. 2010 Feb; 22(1):35-55. Epub 2010 Feb 04.
    View PubMed
  110. Schulz O, Reinicke M, Berghoefer GH, Bensch R, Kraemer J, Schimke I, Jaffe AS. Erratum to High-sensitive cardiac troponin I (hs-cTnl) values in patients with stable cardiovascular disease: An initial foray [Clinica Chimica Acta., 411, (2010), 812-817]. Clin Chim Acta. 2010; 411(17-18):1395-6.
    View PubMed
  111. Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009 Dec 1; 104(11):1472-7. Epub 2009 Oct 14.
    View PubMed
  112. Miller WL, Hartman KA, Hodge DO, Hartman S, Struck J, Morgenthaler NG, Bergmann A, Jaffe AS. Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: a multimarker paradigm. J Cardiovasc Transl Res. 2009 Dec; 2(4):526-35. Epub 2009 Aug 14.
    View PubMed
  113. Frye RL, Simari RD, Gersh BJ, Burnett JC, Brumm S, Myerle K, Jaffe AS, Holmes DR, Lerman A, Terzic A. Ethical issues in cardiovascular research involving humans. Circulation. 2009 Nov 24; 120(21):2113-21.
    View PubMed
  114. Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2009 Oct 27; 54(18):1715-21.
    View PubMed
  115. Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem. 2009 Oct; 55(10):1809-15. Epub 2009 Aug 13.
    View PubMed
  116. Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS. Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. Clin Chem. 2009 Oct; 55(10):1869-75. Epub 2009 Aug 13.
    View PubMed
  117. Saenger AK, Lockwood C, Snozek CL, Milz TC, Karon BS, Scott MG, Jaffe AS. Catecholamine interference in enzymatic creatinine assays. Clin Chem. 2009 Sep; 55(9):1732-6. Epub 2009 Jul 09.
    View PubMed
  118. Neizel M, Futterer S, Steen H, Giannitsis E, Reinhardt L, Lossnitzer D, Lehrke S, Jaffe AS, Katus HA. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol. 2009 Sep; 98(9):555-62. Epub 2009 Jul 07.
    View PubMed
  119. Miller WL, Burnett JC Jr, Hartman KA, Hodge DO, Giuliani I, Minard F, Larue C, Jaffe AS. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide. Clin Chim Acta. 2009 Aug; 406(1-2):119-23. Epub 2009 Jun 11.
    View PubMed
  120. Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, August PA, Kshirsagar AV. Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant. 2009 Aug; 24(8):2452-7. Epub 2009 Mar 26.
    View PubMed
  121. Berridge BR, Pettit S, Walker DB, Jaffe AS, Schultze AE, Herman E, Reagan WJ, Lipshultz SE, Apple FS, York MJ. A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. Am Heart J. 2009 Jul; 158(1):21-9.
    View PubMed
  122. Kavsak PA, Wang X, Henderson M, Ko DT, MacRae AR, Jaffe AS. PAPP-A as a marker of increased long-term risk in patients with chest pain. Clin Biochem. 2009 Jul; 42(10-11):1012-8. Epub 2009 Mar 25.
    View PubMed
  123. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperative myocardial infarction. Circulation. 2009 Jun 9; 119(22):2936-44.
    View PubMed
  124. Hickson LJ, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant. 2009 Jun; 9(6):1354-61. Epub 2009 May 13.
    View PubMed
  125. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, Edwards WD, Gertz MA, Klarich KW. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009 May 12; 119(18):2490-7. Epub 2009 May 04.
    View PubMed
  126. Vasile VC, Babuin L, Ting HH, Bell MR, Orme NM, Yuan BY, Perez JA, Alegria JR, Bellolio F, Haro LH, Jaffe AS. Aborted myocardial infarction: is it real in the troponin era? Am Heart J. 2009 Apr; 157(4):636-41. Epub 2009 Jan 31.
    View PubMed
  127. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival after acute myocardial infarction. Psychosom Med. 2009 Apr; 71(3):253-9. Epub 2009 Feb 27.
    View PubMed
  128. Gerber Y, Dunlay SM, Jaffe AS, McConnell JP, Weston SA, Killian JM, Roger VL. Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community. Atherosclerosis. 2009 Apr; 203(2):593-8. Epub 2008 Aug 07.
    View PubMed
  129. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival following acute myocardial infarction. Psycho Med. 2009 Apr; 1:253-259.
  130. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2009 Mar; 55(3):573-7. Epub 2009 Jan 23.
    View PubMed
  131. Bursi F, Barbieri A, Politi L, Di Girolamo A, Malagoli A, Grimaldi T, Rumolo A, Busani S, Girardis M, Jaffe AS, Modena MG. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. Eur J Vasc Endovasc Surg. 2009 Mar; 37(3):311-8. Epub 2008 Dec 25.
    View PubMed
  132. McConnell JP, Jaffe AS. The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial? Clin Chem. 2009 Jan; 55(1):21-3. Epub 2008 Dec 01.
    View PubMed
  133. Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Clin Chem. 2009 Jan; 55(1):78-84. Epub 2008 Nov 21.
    View PubMed
  134. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem. 2009 Jan; 55(1):85-92. Epub 2008 Nov 06.
    View PubMed
  135. Vasile VC, Babuin L, Rio Perez JA, Alegria JR, Song LM, Chai HS, Afessa B, Jaffe AS. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med. 2009 Jan; 37(1):140-7.
    View PubMed
  136. Peleg A, Jaffe AS, Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clinica Chimica Acta. 2009; 409(1-2):85-89.
  137. Saab PG, Bang H, Williams RB, Powell LH, Schneiderman N, Thoresen C, Burg M, Keefe F, for the ENRICHD Investigators. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: The ENRICHD experience. J Psycho Res. 2009; 67:45-56.
  138. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, Burg MM, Mitchell P, Jaffe AS, Schneiderman N. Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med. 2009; 16(3):248-58.
    View PubMed
  139. Vasile VC, Blauwet LA, Jaffe AS. Serial determination of troponin concentrations in the diagnosis of acute myocardial infarction. Heart and Metabolism. 2009; (43):27-9.
    View PubMed
  140. Vasile VC, Jaffe AS. The biological basis of troponin in heart disease: Possible uses for troponin fragmentology. Heart Metab. 2009(43):5-8.
    View PubMed
  141. Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation. 2008 Nov 18; 118(21):2200-6.
    View PubMed
  142. Arruda-Olson AM, Pellikka PA, Bursi F, Jaffe AS, Santrach PJ, Kors JA, Killian JM, Weston SA, Roger VL. Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. Am Heart J. 2008 Nov; 156(5):810-5. Epub 2008 Sep 09.
    View PubMed
  143. Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, Griffin MD, Jaffe AS. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant. 2008 Nov; 8(11):2352-9. Epub 2008 Sep 10.
    View PubMed
  144. Alpert JS, Thygesen K, White HD, Jaffe AS. Implications of the universal definition of myocardial infarction. Nat Clin Pract Cardiovasc Med. 2008 Nov; 5(11):678-9. Epub 2008 Sep 09.
    View PubMed
  145. Thygesen K, Alpert JS, Jaffe AS, White HD. Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr Opin Crit Care. 2008 Oct; 14(5):543-8.
    View PubMed
  146. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart. 2008 Oct; 94(10):1335-41.
    View PubMed
  147. Trockel M, Burg M, Jaffe A, Barbour K, Taylor CB. Smoking behavior postmyocardial infarction among ENRICHD trial participants: Cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosom Med. 2008 Oct; 70(8):875-82.
    View PubMed
  148. Carney RM, Steinmeyer B, Freedland KE, Blumenthal JA, Stein PK, Steinhoff WA, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Domitrovich PP, Burg MM, Hayano J, Jaffe AS. Nighttime heart rate and survival in depressed patients post acute myocardial infarction. Psychosom Med. 2008 Sep; 70(7):757-63. Epub 2008 Aug 25.
    View PubMed
  149. Jaffe AS. Key issues in the developing synergism between cardiovascular imaging and biomarkers. Clin Chem. 2008 Sep; 54(9):1432-42. Epub 2008 Aug 01.
    View PubMed
  150. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008 Aug; 1(1):10-9.
    View PubMed
  151. Mockel M, Danne O, Muller R, Vollert JO, Muller C, Lueders C, Stork T, Frei U, Koenig W, Dietz R, Jaffe AS. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta. 2008 Jul 17; 393(2):103-9. Epub 2008 Mar 27.
    View PubMed
  152. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, Berkman LF, Watkins LL, Czajkowski SM, Burg MM, Jaffe AS. Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord. 2008 Jul; 109(1-2):133-8. Epub 2008 Jan 11.
    View PubMed
  153. Brune K, Katus HA, Moecks J, Spanuth E, Jaffe AS, Giannitsis E. N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial. Clin Chem. 2008 Jul; 54(7):1149-57. Epub 2008 May 01.
    View PubMed
  154. Hess EP, Thiruganasambandamoorthy V, Wells GA, Erwin P, Jaffe AS, Hollander JE, Montori VM, Stiell IG. Diagnostic accuracy of clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. CJEM. 2008 Jul; 10(4):373-82.
    View PubMed
  155. Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem. 2008 Jun; 54(6):1060-5. Epub 2008 Apr 17.
    View PubMed
  156. Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide. Int J Cardiol. 2008 May 23; 126(2):234-9. Epub 2007 May 07.
    View PubMed
  157. Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem. 2008 Apr; 54(4):747-51.
    View PubMed
  158. Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS. Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? Clin Biochem. 2008 Apr; 41(6):436-9. Epub 2007 Dec 27.
    View PubMed
  159. Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol. 2008 Mar 10; 26(8):1231-8. Epub 2008 Feb 04.
    View PubMed
  160. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, NACB Committee, IFCC C-SMCD. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. Clin Biochem. 2008 Mar; 41(4-5):222-6. Epub 2007 Nov 26
    View PubMed
  161. Dal-Bianco JP, Jaffe AS, Bell MR, Oh JK. Cardiac function and brain-type natriuretic peptide in first-time flash pulmonary edema. Mayo Clin Proc. 2008 Mar; 83(3):289-96.
    View PubMed
  162. Lopez-Jimenez F, Wu CO, Tian X, O'Connor C, Rich MW, Burg MM, Sheps D, Raczynski J, Somers VK, Jaffe AS. Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. Am Heart J. 2008 Mar; 155(3):478-84. Epub 2008 Jan 15.
    View PubMed
  163. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008 Mar; 36(3):759-65.
    View PubMed
  164. Moller JE, Bergeron S, Jaffe A, Pellikka PA. Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease. Int J Cardiol. 2008 Feb 29; 124(2):204-10. Epub 2007 Apr 18.
    View PubMed
  165. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J. 2008 Feb; 155(2):208-14. Epub 2007 Dec 19.
    View PubMed
  166. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol. 2008 Jan 22; 51(3):307-14.
    View PubMed
  167. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, Macrae AR, Jaffe AS. "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clin Chim Acta. 2008 Jan; 387(1-2):133-8. Epub 2007 Oct 03.
    View PubMed
  168. Miller WL, Jaffe AS. Serial biomarker measurements in chronic heart failure. Cardiology Review. 2008; 25(3):53-8.
    View PubMed
  169. Saenger AK, Jaffe AS. Requiem for a heavyweight. Circ. 2008; 118:2200-2206.
  170. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytical and clinical utility of a next generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2008.
  171. Jaffe AS. The clinical impact of the universal diagnosis of myocardial infarction. Clin Chem Lab Med. 2008; 46(11):1485-8.
    View PubMed
  172. Hess EP, Wells GA, Jaffe A, Stiell IG. A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology. BMC Emerg Med. 2008; 8:3. Epub 2008 Feb 06.
    View PubMed
  173. Miller WL, Targonski PV, Jaffe AS. B-type natriuretic peptides in heart failure: update on clinical applications and limitations. Biomark Med. 2007 Dec; 1(4):503-12.
    View PubMed
  174. Vasile VC, Jaffe AS. New potential uses for cardiac troponins. Biomark Med. 2007 Dec; 1(4):491-501.
    View PubMed
  175. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem. 2007 Dec; 53(12):2112-8. Epub 2007 Oct 11.
    View PubMed
  176. Wu AHB, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, Newby LK, Ravkilde J, Tang WHW, Christenson RH, Cannon CP, Storrow AB. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007 Dec; 53(12):2086-96.
    View PubMed
  177. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed II, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007 Nov 20; 116(21):2420-6.
    View PubMed
  178. Lee-Lewandrowski E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, Wong A, Murakami MM, Kaczmarek J, Apple FS, Miller WL, Hartman K, Jaffe AS. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Clin Chim Acta. 2007 Nov-Dec; 386(1-2):20-4. Epub 2007 Jul 25.
    View PubMed
  179. Schulz O, Paul-Walter C, Lehmann M, Abraham K, Berghoefer G, Schimke I, Jaffe AS. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol. 2007 Sep 1; 100(5):766-71.
    View PubMed
  180. Binder J, Ommen SR, Chen HH, Ackerman MJ, Tajik AJ, Jaffe AS. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007 Aug 15; 100(4):712-4. Epub 2007 Jun 19.
    View PubMed
  181. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007 Aug 14; 116(7):729-36. Epub 2007 Aug 01.
    View PubMed
  182. Ghearing GR, Munger TM, Jaffe AS, Benarroch EE, Britton JW. Clinical cues for detecting ictal asystole. Clin Auton Res. 2007 Aug; 17(4):221-6. Epub 2007 Jul 16.
    View PubMed
  183. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH, Cannon CP, Francis G, Jesse RL, Morrow DA, Newby LK, Storrow AB, Tang WH, Pagani F, Tate J, Ordonez-Llanos J, Mair J, National Academy of Clinical Biochemistry, IFCC Committee for Standardization of National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. Circulation. 2007 Jul 31; 116(5):e95-8. Epub 2007 Jul 14.
    View PubMed
  184. Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, Jaffe AS. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007 Jul 17; 116(3):249-57. Epub 2007 Jun 25.
    View PubMed
  185. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, Burg MM, Mitchell P, Jaffe AS, Schneiderman N. Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol. 2007 Jul; 26(4):418-27.
    View PubMed
  186. Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am. 2007 Jul; 91(4):657-81; xi.
    View PubMed
  187. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta. 2007 May 1; 380(1-2):213-6. Epub 2007 Jan 23.
    View PubMed
  188. Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol. 2007 May; 30(5):245-50.
    View PubMed
  189. Jaffe AS. Cardiovascular biomarkers: the state of the art in 2006. Clin Chim Acta. 2007 May; 381(1):9-13. Epub 2007 Feb 22.
    View PubMed
  190. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, National Academy of Clinical Biochemistry, IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007 Apr 3; 115(13):e352-5. Epub 2007 Mar 23.
    View PubMed
  191. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon CP, Francis G, Morrow DA, Ravkilde J, Storrow AB, Tang W, IFCC Comittee on Standardization of Markers of Cardiac Damege, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Panteghini M, Tate J, Nation National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem. 2007 Apr; 53(4):547-51. Epub 2007 Mar 23.
    View PubMed
  192. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem. 2007 Mar; 40(5-6):326-9.
    View PubMed
  193. Friedewald VE, Arnold LW, Carney RM, Jaffe AS, Sheps DS, Roberts WC. The Editor's Roundtable: major depression in patients with coronary heart disease. Am J Cardiol. 2007 Feb 15; 99(4):519-29.
    View PubMed
  194. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem. 2007 Feb; 53(2):220-7. Epub 2007 Jan 04.
    View PubMed
  195. Carney RM, Howells WB, Blumenthal JA, Freedland KE, Stein PK, Berkman LF, Watkins LL, Czajkowski SM, Steinmeyer B, Hayano J, Domitrovich PP, Burg MM, Jaffe AS. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med. 2007 Jan; 69(1):4-9. Epub 2006 Dec 13.
    View PubMed
  196. Hermsen D, Apple F, Garcia-Beltran L, Jaffe A, Karon B, Lewandrowski E, Muhlbacher A, Muller R, Ordonez J, Pagani F, Panteghini M, Plecko T, Jarausch J. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab. 2007; 53(1-2):1-9.
    View PubMed
  197. Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, Grieg Z, Alexander JH, Jaffe AS, Van Eyk JE, Atar D. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res. 2006 Nov 10; 99(10):1141-7. Epub 2006 Oct 12.
    View PubMed
  198. Gerber Y, McConnell JP, Jaffe AS, Weston SA, Killian JM, Roger VL. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2517-22. Epub 2006 Aug 10.
    View PubMed
  199. Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naive emergency department patients. Clin Chem. 2006 Nov; 52(11):2028-35. Epub 2006 Sep 21.
    View PubMed
  200. Roger VL, Killian JM, Weston SA, Jaffe AS, Kors J, Santrach PJ, Tunstall-Pedoe H, Jacobsen SJ. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation. 2006 Aug 22; 114(8):790-7. Epub 2006 Aug 14.
    View PubMed
  201. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006 Jul 4; 48(1):1-11. Epub 2006 Jun 12.
    View PubMed
  202. Jaffe AS, Krumholz HM, Catellier DJ, Freedland KE, Bittner V, Blumenthal JA, Calvin JE, Norman J, Sequeira R, O'Connor C, Rich MW, Sheps D, Wu C, Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Trial Investigators. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J. 2006 Jul; 152(1):126-35.
    View PubMed
  203. Rana R, Vlahakis NE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med. 2006 Jul; 34(7):1941-6.
    View PubMed
  204. Parvulescu-Codrea S, Britton JW, Bruce CJ, Cascino GD, Jaffe AS. Elevations of troponin in patients with epileptic seizures? What do they mean? Clin Cardiol. 2006 Jul; 29(7):325-6.
    View PubMed
  205. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J. 2006 Jul; 152(1):118-25.
    View PubMed
  206. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006 Jun 16; 110(2):153-9. Epub 2005 Jul 25.
    View PubMed
  207. Lanman RB, Wolfert RL, Fleming JK, Jaffe AS, Roberts WL, Warnick GR, McConnell JP. Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults. Prev Cardiol. 2006 Summer; 9(3):138-43.
    View PubMed
  208. Macrae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem. 2006 May; 52(5):812-8. Epub 2006 Mar 23.
    View PubMed
  209. Miller WL, Garratt KN, Burritt MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 2006 May; 27(9):1061-9. Epub 2006 Feb 15.
    View PubMed
  210. Wright RS, Bybee K, Miller WL, Laudon DA, Murphy JG, Jaffe AS. Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI. Int J Cardiol. 2006 Apr 14; 108(3):314-9. Epub 2005 Jun 22.
    View PubMed
  211. Williams BA, Wright RS, Murphy JG, Brilakis ES, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emerg Med J. 2006 Mar; 23(3):186-92.
    View PubMed
  212. Maramattom BV, Manno EM, Fulgham JR, Jaffe AS, Wijdicks EF. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc. 2006 Feb; 81(2):192-6.
    View PubMed
  213. Rana R, Vlahakis NE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O. Uitlity of Early Measurement of Plasma B Type Natriuretic Peptide in the Assessment of Acute Lung Injury and Cardiogenic Pulmonary Edema. Critical Care Medicine. 2006; 33(12):A20.
    View PubMed
  214. Miller WL, Edwards BS, Kremers WK, Kushwaha SS, McGregor CGA, Daly RC, Jaffe AS. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant. 2005 Dec; 24(12):2075-8.
    View PubMed
  215. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005 Nov 8; 173(10):1191-202.
    View PubMed
  216. Bursi F, Babuin L, Barbieri A, Politi L, Zennaro M, Grimaldi T, Rumolo A, Gargiulo M, Stella A, Modena MG, Jaffe AS. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. Eur Heart J. 2005 Nov; 26(22):2448-56.
    View PubMed
  217. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005 Nov; 51(11):2198-200.
    View PubMed
  218. Jaffe AS. Use of biomarkers in the emergency department and chest pain unit. Cardiol Clin. 2005 Nov; 23(4):453-65, vi.
    View PubMed
  219. Gheorghiade M, Stough WG, Adams KF, Jaffe AS, Hasselblad V, O'Connor CM. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). Am J Cardiol 2005 Sep 19; 96(6A Suppl S):18G-25G.
    View PubMed
  220. Miller WL, Burnett JC Jr, Hartman KA, Henle MP, Burritt MF, Jaffe AS. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005 Sep 15; 96(6):837-41.
    View PubMed
  221. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Domitrovich PP, Jaffe AS. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005 Jul 11; 165(13):1486-91.
    View PubMed
  222. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, Kaufmann PG, Shuster J, Mellman T, Blumenthal JA, Krishnan R, Jaffe AS. Effects of antideressant medication of morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005 Jul; 62(7):792-8.
    View PubMed
  223. Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV. Practical Implementation of the guidelines for unstable angina/non-st-segment elevation myocardial infarction in the emergency department. Ann Emergency Med. 2005,May 24; 111:2699 - 270.
  224. Apple FS, Wu AHB, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005 May; 51(5):810-24.
    View PubMed
  225. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AHB, Tate J, Pagani F, Christenson RH, Jaffe AS. Quality specifications for B-type natriuretic peptide assays. Clin Chem. 2005 Mar; 51(3):486-93.
    View PubMed
  226. Miller WL, Hartman KA, Burritt MF, Borgeson DD, Burnett JC Jr, Jaffe AS. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. Clin Chem. 2005 Mar; 51(3):569-77. Epub 2004 Dec 22.
    View PubMed
  227. Williams BA, Wright RS, Murphy JG, Miller WL, Reeder GS, Jaffe AS. A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emergency Medical Journal. 2005.
    View PubMed
  228. Miller WL, Burnett Jr JC, Hartman KA, Henle MP, Burritt MF, Jaffe AS. Lower Rather Than Higer Levels of B-Type Natriuretic Peptides (NT-Pro-BNP) Predict short-Term Mortality in End-Stage Heart Failure Patients Treated With Nesiritide. Am J Cardio. 2005; 96:837-841.
    View PubMed
  229. Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV. Practical implementation of the guidelines for unstable angina/non-st-segment elevation myocardial infarction in the emergency department. Circulation. 2005; 111:2699-2710.
    View PubMed
  230. Gheorghiade M, Gattis Stough W, Pharm D, Adams Jr KF, Jaffe AS, Hasselbland V, O'Connor CM. The PRESERVD-HF Study. AJC Supplement. 2005(18G - 25G).
    View PubMed
  231. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004 Oct 19; 44(8):1533-42.
    View PubMed
  232. Gulati M, Patel S, Jaffe AS, Joseph AJ, Calvin JE. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in the registry of acute coronary syndromes. Am J Cardiol. 2004 Oct 1; 94(7):873-8.
    View PubMed
  233. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004 Sep 15; 22(18):3751-7.
    View PubMed
  234. Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol. 2004 Sep 15; 22(18):3700-4.
    View PubMed
  235. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, McConnell JP, Litzow MR, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata LF, Elliott MA, Hogan WJ, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Zeldenrust S Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2004 Sep 15; 104(6):1881-7.
    View PubMed
  236. Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004 Aug 1; 94(3):343-6.
    View PubMed
  237. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski SM, Jaffe AS. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004 Jul-Aug; 66(4):466-74.
    View PubMed
  238. La Vecchia L, Ottani F, Favero L, Spadaro GL, Rubboli A, Boanno C, Mezzena G, Fontanelli A, Jaffe AS. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart (British Cardiac Society) 2004 Jun; 90(6):633-7.
    View PubMed
  239. Gami AS, Svatikova A, Wolk R, Olson EJ, Duenwald CJ, Jaffe AS, Somers VK. Cardiac troponin T in obstructive sleep apnea. Chest. 2004 Jun; 125(6):2097-100.
    View PubMed
  240. Gami AS, Jaffe AS. 60-year-old man with chest pain. Mayo Clin Proc. 2004 Mar; 79(3):399-402.
    View PubMed
  241. Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest. 2004 Jan; 125(1):275-80.
    View PubMed
  242. Perez E, Suman V, Davidson N, Kaufman P, Martino S, Dakhil S, Rodeheffer R, Gersh B, Jaffe A Effect of Dozorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients With Breast Cancer in the NCCTG N9831 Intergroup Adjuvant Trial J Clin Pathol. 2004; 22:3700-3704.
    View PubMed
  243. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Jaffe AS. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003 Dec 1; 92(11):1277-81.
    View PubMed
  244. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003 Nov 18; 108(20):2543-9.
    View PubMed
  245. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Effects of treating depression and low-perceived social support on clinical events after myocardial infarction - The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA: Journal of the American Medical Association. 2003 Jun 18; 289(23):3106-16.
    View PubMed
  246. Woodruff BK, Britton JW, Tigaran S, Cascino GD, Burritt M, McConnell JP, Ravkilde J, Molgaard H, Andreasen F, Dam M, Jaffe AS. Cardiac troponin levels following monitored epileptic seizures. Neurology. 2003 May 27; 60(10):1690-2.
    View PubMed
  247. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, Burritt MF, Jaffe AS. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet. 2003 May 24; 361(9371):1787-9.
    View PubMed
  248. Carney RM, Freedland KE, Stein PK, Watkins LL, Catellier D, Jaffe AS, Yeragani VK. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med. 2003 Mar-Apr; 65(2):177-80.
    View PubMed
  249. Tigaran S, Molgaard H, McClelland R, Dam M, Jaffe AS. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology. 2003 Feb 11; 60(3):492-5.
    View PubMed
  250. Gheorghiade M, Gattis WA, Adams KF, Jaffe AS, O'Connor CM. Rationale and design of the Pilot Randomized Study of Nesiritide versus Dobutamine in Heart Failure (PRESERVD-HF). Am Heart J. 2003 Feb; 145(2 Suppl S):S55-7.
    View PubMed
  251. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003 Jan-Feb; 65(1):119-28.
    View PubMed
  252. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002 Dec; 144(6):981-6.
    View PubMed
  253. Aviles RJ, Wright RS, Aviles JM, McDonald F, Ballman K, Harker-Murray A, Scott C, Lauer MS, Kopecky SL, Jaffe AS. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin I levels. Am J Cardiol. 2002 Oct 15; 90(8):875-8.
    View PubMed
  254. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002 Oct 1; 137(7):563-70.
    View PubMed
  255. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity - A review of potential mechanisms. J Psychosom Res. 2002 Oct; 53(4):897-902.
    View PubMed
  256. Wright RS, Williams BA, Cramner H, Gallahue F, Willmore T, Lewis L, Ladenson JH, Jaffe AS. Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. Am J Cardiol. 2002 Sep 15; 90(6):634-6.
    View PubMed
  257. Carlson RJ, Navone A, McConnell JP, Burritt M, Castle MC, Grill D, Jaffe AS. Effect of myocardial ischemia on cardiac troponin I and T. Am J Cardiol. 2002 Jan 15; 89(2):224-6.
    View PubMed
  258. Cantwell RV, Aviles RJ, Bjornsson J, Wright RS, Freeman WK, Oh JK, Hoyer JD, Markovic S, Jaffe AS. Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol. 2002 Jan; 25(1):33-7.
    View PubMed
  259. McConnell JP, Branum EL, Ballman KV, Lagerstedt SA, Katzmann JA, Jaffe AS. Gender differences in C-reactive protein concentrations - Confirmation with two sensitive methods. Clinical Chemistry & Laboratory Medicine. 2002; 40(1):56-9.
    View PubMed
  260. Jaffe AS, World Health Organization, European Society of Cardiology, American College of Cardiology. New standard for the diagnosis of acute myocardial infarction. Cardiol Rev. 2001 Nov-Dec; 9(6):318-22.
    View PubMed
  261. Miller WL, Wright RS, McGregor CG, Dispenzieri A, McConnell JP, Burritt MF, Jaffe AS. Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation. Am J Cardiol. 2001 Oct 1; 88(7):813-5.
    View PubMed
  262. ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med. 2001 Sep-Oct; 63(5):747-55.
    View PubMed
  263. Antman EM, Corbalan R, Huber K, Jaffe AS. Issues in early risk stratification for UA/NSTEMI. European Heart Journal Supplement. 2001 Aug; 3(J):J6-J14.
    View PubMed
  264. Jaffe AS. Diagnosis of Acute Myocardial Infarction: The Use of Troponin Markers. Israeli Heart Journal. 2001.
  265. Jaffe AS. Elevations in cardiac troponin measurements: false false-positives: the real truth. Cardiovasc Toxicol. 2001; 1(2):87-92.
    View PubMed
  266. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. The ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD): Baseline Characteristics. Amer J Card. 2001; 88:316-22.
  267. Jacobs I, Callanan V, Nichol G, Valenzuela T, Mason P, Jaffe AS, Landau W, Vetter N. The Chain of Survival. Annals of Emergency Medicine/Journal of the American College of Emergency Physicians S5 2001; 37(4).
  268. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, Jaffe AS. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000 Dec; 140(6):917-27.
    View PubMed
  269. Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med. 2000 Nov 13; 160(20):3153-8.
    View PubMed
  270. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med. 2000 Sep-Oct; 62(5):639-47.
    View PubMed
  271. Alpert JS, Antman E, Apple F, Armstrong PW, Bassand JP, de Luna G, Breithardt G, Chaitman BR, Clemmensen P, Falk E, Fishbein MC, Galvani M, Garson A, Grines C, Hamm C, Jaffe AS, Katus H, Kjekshus J, Klein W, Klootwijk P, Lenfant C, Levy D, Levy RI, Luepke Myocardial infarction redefined - A consensus document of the Joint European Society of cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Journal of the American College of Cardiology. 2000 Sep; 36(3):959-69.
    View PubMed
  272. Hutter AM, Amsterdam EA, Jaffe AS. Task force 2: acute coronary syndromes: Section 2B - chest discomfort evaluation in the hospital. J Am Coll Cardiol. 2000 Mar 15; 35(4):853-862.
    View PubMed
  273. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, Rottman JN. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. Journal of Psychosomatic Research. 2000; 48:493-500.
  274. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Enhancing recovery in coronary heart disease (ENRICHD) patients study: Study design and methods. American Heart Journal. 2000; 139:1-9.
    View PubMed
  275. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2000; 66:639-47.
  276. Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, Lynch T, Jaffe AS. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry. 1999 Feb 15; 45(4):458-63.
    View PubMed
  277. Carney RM, Freedland EK, Veith RC, Jaffe AS. Can treating depression reduce mortality after an acute myocardail infarction? Psychosomatic Medicine. 1999; 61:666-75.
    View PubMed
  278. Ottani F, Galvani M, Ferrini D, Ladenson JH, Puggioni R, Destro A, Baccos D, Bosi S, Ronchi A, Rusticali, Jaffe AS. Direct comparison of early elevations of cardiac troponin T and I in patients with unstable angina. AHJ. 1999; 137:284-91.
    View PubMed
  279. Jaffe AS. The use of troponin measurements in patients with unstable angina. International Journal of Cardiology 68 Suppl. 1999; 1:S49-53.
  280. Jaffe AS. 2001--a biomarker odyssey. Clin Chim Acta. 1999 Jun 30;284(2):197-211.
  281. Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS. Adherence to a prophyllactic medication regimen in patients with symptomatic vs asymptomatic ischemic heart disease Behavioral Medicine. 1998; 24:35-9.
    View PubMed
  282. Jaffe AS, Landau WM, Wetzel RD. Resuscitation 2000: the need for improved databases in regard to neurological outcomes. Resuscitation. 1998; 37:65-6.
    View PubMed
  283. Landt M, Lawson GM, Helgeson JM, Davila-Roman VG, Ladenson JH, Jaffe AS, Hickner RC. Prolonged exercise decreases serum leptin concentrations. Metabolism: Clinical & Experimental. 1997 Oct; 46(10):1109-12.
    View PubMed
  284. Selis SP, Hom M, Sequeira JM, Tritel M, Gindea A, Ladenson JH, Jaffe AS, Esposito R. Time course of lysophosphatydylcholine relase from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia Coron Art Disease. 1997; 8:19-27.
  285. Davila-Roman V, Guest TH, Tuteur PG, Rowe WJ, Ladenson JH, Jaffe AS. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude JACC. 1997; 30:468-73.
    View PubMed
  286. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates Circulation. 1997; 95:163-8.
    View PubMed
  287. Hirsch R, Landt Y, Porter S, Canter CE, Jaffe AS, Ladenson JH, Grant JW, Landt M. Cardiac troponin I in Pediatrics: Normal values and potential use in the assessment of cardiac injury J Peds. 1997; 130:827-72.
  288. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, Rusticali F, Jaffe AS. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 1997; 95:2053-9.
    View PubMed
  289. Allan JJ, Feld RD, Russell AA, Ladenson JH, Rogers MAM, Kerber RI, Jaffe AS. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion JACC. 1997; 30:1052-6.
    View PubMed
  290. Jaffe AS. More rapid diagnosis of myocardial infarction: Is it worthwhile? American Family Physician. 1997; 55:2591-2594.
    View PubMed
  291. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for the diagnosing acute myocardial infarction Clin Chem. 1996; 42:1770-6.
    View PubMed
  292. Adams JE, Davila-Roman VG, Bessey PQ, Blake DP, Ladenson JH, Jaffe AS. Improved detection of cardiac contusion with cardiac troponin I Am Heart J. 1996; 131:308-12.
    View PubMed
  293. Jaffe AS. Rationale for the use of conjunctive anticoagulation during thrombolysis. In Review in Depth Sobel BE Coron Art Dis. 1996; 7:491-6.
  294. Fiedotin NA, Freedland KE, Carney RM, Skala JA, Rich MW, Jaffe AS. Depression, medical utilization in patients in chronic heart failure. Annuals of Behavioral Medicine. 1996:S134.
  295. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms. Ann Behav Med. 1995 Spring; 17(2):142-9.
    View PubMed
  296. Guest TM, Ramanathan AV, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill medical patients: A surprisingly frequent complication JAMA 49 1995 1945-19; 273:1945-9.
  297. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease Health Psychology. 1995; 14:88-90.
    View PubMed
  298. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease AJC. 1995; 76:562-4.
  299. Grant JW, Canter CE, Spray TL, Landt Y, Saffitz JE, Ladenson JH, Jaffe AS. Elevated donor cardiac troponin I: A marker of acute graft failure in infant heart recipients Circulation. 1994; 90:2618-21.
    View PubMed
  300. Lenke LG, Bridwel KH, Jaffe AS. Increase inc reatine kinase MB isoenzyme levels and spinal surgery J Spinal Disorders. 1994; 7:70-6.
  301. Adams JE III, Schechtman K, Landt V, Landenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I Clin Chem 7 1994; 40:1291-5.
  302. Jaffe AS, Eisenberg PR, Abendschein DR. Conjoint use of MM and MB creatine kinase isoforms for detection of coronary recanalization Am Heart J. 1994; 127:1461-6.
    View PubMed
  303. Adams JE, Sicard G, Allan BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with masurement of cardiac troponin I N Engl J Med. 1994; 330:670-4.
    View PubMed
  304. Adams JE 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993 Jul; 88(1):101-6.
    View PubMed
  305. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Hemodynamic effects of atrial ineraction Cor ARt Dis. 1993; 4:545-53.
  306. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease Am J Med. 1993; 95:23-8.
    View PubMed
  307. Eisenberg MS, Aghababian RV, Bossaert L, Jaffe AS, Ornato JP, Weaver WD. Thrombolytic therapy. Ann Emerg Med. 1993; 22:417-27.
    View PubMed
  308. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990's? Circulation. 1993; 88:750-63.
    View PubMed
  309. Jaffe AS, Landau WM. Clinical neuromythology XI death after death: The presumption of informed consent for CPR, ethical paradox, clinical conundrum. Neurology. 1993; 43:2173-8.
    View PubMed
  310. Jaffe AS. The use of antiarrhythmias in advanced cardiac life support. Ann Emerg Med. 1993; 22:307-16.
    View PubMed
  311. Jaffe AS, Deedwania PC, Higginson LA, Boden WE, Mehta JL, Ferlinz J, Walsh RA, Sullivan JM, Vokonas PS, Cabin H, et al. Diagnostic and therapeutic implications: exploration through case discussions. Am J Cardiol. 1992 Nov 16; 70(16):45F-48F.
    View PubMed
  312. Jaffe AS. The use of intravenous diltiazem in patients with acute coronary artery disease. Am J Cardiol. 1992; 69:25B-9B.
    View PubMed
  313. Jaffe AS. Effects of diabetes on the heart. (Overview) Cor Artery Dis. 1992; 3:1-3.
  314. Eisenberg PR, Sobel BE, Jaffe AS. Activation of prothrombin accompanying thrombolysis with rt-PA JACC. 1992; 19:1065-9.
    View PubMed
  315. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Importance of LV function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia JACC. 1992; 19:704-11.
    View PubMed
  316. Freedland KE, CArney RM, Lustman PJ, Rich MW, Jaffe AS. Major depression in coronary artery disease, patients with versus without a prior history of depression Psychosomatic Med. 1992; 54:416-21.
  317. Adams JE, Siegel BA, Goldstein JA, Jaffe AS. Elevations of CK-MB following pulmonary embolism: A manifestation of occult right ventricular infarction Chest. 1992; 101:1203-6.
    View PubMed
  318. Goldstein JA, Kenzora JL, Jaffe AS. Coronary angiography with a novel mobile x-ray image intensifier Coronary ARtery Dis. 1992; 3:1065-71.
  319. Carney RM, Freedland KE, Clark KA, Skala JA, Smith L, Delamater A, Jaffe AS. Psychosocial adjustment of patients arriving early at the emergency department after acute myocardial infarction Am J Cardiol. 1992; 69:160-2.
    View PubMed
  320. Prager NA, Suzuki T, Jaffe AS, Sobel BE, Abendschein DR. The nature and time course of generation of isoforms of MB creatine kinase in vivo JACC. 1992; 20:414-9.
    View PubMed
  321. Carney RM, Freedland KE, Smith LJ, Rich MW, Jaffe AS. Relation of depression and mortality after myocardial infarction in women. Circulation. 1992; 84:1876-77.
  322. Jaffe AS, Emergency Cardiac Care Committee. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care JAMA. 1992; 268:2171-81.
    View PubMed
  323. Atkins JM, Mentzer RM, Field JM, Ornato JP, Francis CK, Passamani ER, Gibson RS, Prediman KS, Goldberg SJ, Smith HC, et al. Recommended guidelines for in-hospital cardiac monitoring of adults for detection of arrhythmia. Am Coll Cardiol. 1991; 18(6):1431-3.
  324. Goldstein JA, Tweddell JS, Barzilai B, Yagi Y, Jaffe AS, Cox JL. Right atrial ischemia exacerbates hemodynamic compromise associated with experimental right ventricular dysfunction JACC. 1991; 18:564-72.
  325. Eisenberg PR, Kenzora J, Sobel BE, Ludbrook PA, Jaffe AS. Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina JACC. 1991; 18:893-903.
  326. Abendschein DA, Ellis AK, Eisenberg PR, Klocke FJ, Sobel BE, Jaffe AS. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma Cor ARt Dis. 1991; 2:201-12.
  327. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL, Jaffe AS, Cryer PE, Hanto DW, Anderson CB, Flye MW. Results of our first nine intraportal islet allografts in type I insulin dependent diabetic patients Transplantation. 1991; 51:76-85.
    View PubMed
  328. Hartwell TD, Parker CB, Poole WK, Davis VG, Muller JE, Braunwald E, Robertson T, Rutherford J, Sobel BE, Strauss W, Thomas L, Roberts R, Jaffe AS, Willerson JT. Reproducibility of centralized laboratory interpretations of measures of myocardial infarct size, ventricular function, and ventricular electrical instability scintigraphy Coronary ARtery Disease. 1991; 2:997-84.
  329. Carney RM, Freedland KE, Jaffe AS. Altered circadian variation of acute myocardial infarction in patients with depression Coronary Artery Disease. 1991; 2:61-5.
  330. Cummins RO, Ornato JP, Thies WH, Pepe PE, Billi JE, Seidel J, Jaffe AS, Flint LS, Goldstein S, Abramson NS, Brown C, Chandra NC, Gonzalez ER, Newell L, Stults KR, Membrino GE. Improving survival from sudden cardiac arrest: The "Chain of Survival" Concept. Circulation. 1991; 83:1832-47.
    View PubMed
  331. Jaffe AS. Automated defibrillation: A problem, a challenge and an opportunity - The role of Internists and cardiologists in the prehospital care of their patients Cont Intern Med 8-1 1990.
  332. Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Elevations of levels of fibrinopeptid A indicative of pulmonary vascular thrombosis in patient with primary pulmonary hypertension Circulation. 1990; 82:841-7.
    View PubMed
  333. Carney RM, Freedland KE, Jaffe AS. Insomnia and Depression Prior to Myocardial Infarction Psychosomatic Medicine. 1990; 52:603-9.
    View PubMed
  334. Winters KJ, Eisenberg PR, JAffe AS, Santoro SA. Dependence of plasmin-mediated degradation of platelet adhesive receptors on temperature and CA++ concentration Blood. 1990; 76:1546-57.
    View PubMed
  335. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, Marchetti P, Gingerish RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW. Insulin independence after Islet transplantation into Type I diabetic patient Diabetes. 1990; 39:515-18.
    View PubMed
  336. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP. Normal left ventricular function in children with x-linked hypophosphatemic rickets. A Doppler echocardiography study J Bone Min Res. 1990; 5:469-74.
  337. Carney RM, Freeland KE, Ludbrook PA, Saunders RD, Jaffe AS. Major depression, panic disorder, and mitral valve prolapse in patients who complainof chest pain Am J Med. 1990; 89:757-60.
    View PubMed
  338. Goldstein JA, Barzilai B, Rosamond TL, Eisenberg PR, Jaffe AS. Determinants of hemodynamic compromise with severe right ventricular infarction Circulation. 1990; 82:469-368.
  339. Eisenberg PR, Jaffe AS, Stump DC, Collen DJ, Bovill EG. Validity of enzyme-linked immunoabsorbent assays of cross-linked fibrin degradation products as a measure of clot lysis Circulation. 1990; 82:1159-68.
    View PubMed
  340. Barzilai B, Davis VG, Stone PH, Jaffe AS, MILIS study group. Prognostic significance fo mitral regurgitation in acute myocardial infarction AM J Cardiol. 1990; 65:1169-75.
    View PubMed
  341. Cohen ML, Barzilai B, Gutierrez F, Jaffe AS, Eisenberg P. Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator. Am Heart J. 1990; 120:978-9.
    View PubMed
  342. Cummins RO, Thies W, Paraskos J, Kerber RE, Billi JE, Seidel J, Jaffe AS, Flint L, Ornato JP, Abramson NS, Brown C, Chandra NC, Gonzales ER, Newell L, Stults KR, Membrino GE, Pepe PE. Encouraging early defibrillation: The American Heart Association and automated external defibrillation. Ann Emerg Med. 1990; 19:1245-8.
    View PubMed
  343. Carney RM, Freedland KE, Sapira JD, Jaffe AS. Panic disorder and depression in patients with chest pain not due to coronary artery disease. Am J Cardiol (letter) 1990; 15:1048.
  344. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP. Normal left ventricular performance documented by Doppler echocardiography in patients with longstanding hypocalcemia AM J Med. 1989; 86:413-6.
    View PubMed
  345. Eisenberg PR, Shaw D, Schaab C, Jaffe AS. Concordance of creatine kinase-MB activity and mass Clin Chem. 1989; 35:440-3.
    View PubMed
  346. Scharp D, Lacy P, Ricordi C, Boyle P, Santiago J, Cryer P, Gingerick R, Jaffe AS, Anderson C, Flye W. Human islet transplantation in patient with type-1 diabetes Transplant Proc. 1989; 21:2744-5.
    View PubMed
  347. Carney RM, Freedland K, Rich MW, Jaffe AS. Stimulus induced analgesia and silent myocardial ischemia. J Appl Cardiol. 1989; 4:271-4.
  348. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss WH, Willerson JT, Sobel BE, Robertson T, Passamani E, Braunwald E, Jaffe AS, MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis J Am Coll Cardiol. 1989; 14:49-57.
    View PubMed
  349. Devries S, Jaffe AS, Geltman EM, Sobel BE, Abendschein D. Enzymatic estimation of the extent of irreversible myocardial injury early after reperfusion. Am Heart J. 1989; 117:31-6.
    View PubMed
  350. Jaffe AS, TIMI study group. Comparison of invaasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) phase II trial N Engl J Med. 1989; 320:618-27.
    View PubMed
  351. Jaffe AS. Cardiovascular effects of diabetes. Curr Opin in Cardiol. 1989; 4:711-20.
  352. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, Rutherford JD, Poole WK, Passamani E, Willerson JT, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol. 1988 Mar; 11(3):453-63.
    View PubMed
  353. Eisen HJ, Barzilai B, Jaffe AS, Geltman EM. Relationship of QRS scoring system to enzymatic and pathologic infarct size: The role of infarct location. Am Heart J. 1988; 115:993-1001.
    View PubMed
  354. Muller JE, Rude RE, Baunwald E, Hartwell TD, Roberts R, Sobel BE, Ritter C, Parker CB, Jaffe AS, Stone PH, Raabe DS, Willerson JT, Robertson T, MILIS study group. Myocardial infarct extension: Incidence, outcome, and risk factors in the MILIS study. Ann Intern Med. 1988; 108:1-6.
    View PubMed
  355. Roberts R, Braunwald E, Muller JE, Croft C, Gold HK, Hartwell TD, Jaffe AS, Mullin SM, Parker C, Passamani ER, Poole K, Robertson T, Raabe DS, Rude RE, Stone PH, Turi ZG, Sobel BE, Willerson JT, MILIS study group. The effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma MB CK and nontransmural ischemia: Retrospective analysis of MILIS data. Br Heart J. 1988; 60:290-8.
    View PubMed
  356. Eisenberg PR, Miletich JP, Sobel BE, Jaffe AS. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA). Thrombosis Res. 1988; 50:707-17.
  357. Rao AK, Pratt C, Berke A, Jaffe AS, Ockene I, Schreiber TL, Bell Knatterud G, Robertson TL, Terrin ML, for the TIMI Investigators. The thrombolysis in myocardial infarction trial - Phase I. Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Col Cardiol. 1988; 11:1-11.
  358. Seacord LM, Abendschein DR, Nohara R, Hartzler G, Sobel BE, Jaffe AS. Detection of reperfusion within one hour after coronary recanalization by analysis of isoforms of the MM creatine kinase isoenzyme in plasma Fibrinolysis. 1988; 2:151-6.
  359. Nohara R, Sobel BE, Jaffe AS, Abendschein DR. Quantitative analysis of isoforms of creatine kinase MM in plasma by chromatofocusing with on-line monitoring of enzyme activity Clin Chem 2 1988; 34:235-9.
  360. Lee RT, Lee TH, Poole WK, Gustafson N, Stone PH, Jaffe AS, Muller JE, Sobel BE, Braunwald E, MILIS study group. Rate of disappearance of creatine kinase and creatine kinase-MB after acute myocardial infarction. Clinical determinants of variability Am Heart J. 1988; 116:661-4.
  361. Abendschein D, Seacord LM, Nohara R, Sobel BS, Jaffe AS. Prompt detection of myocardial injury by assay of creatine kinase isoforms in initial plasma samples Clin Cardiol. 1988; 11:661-4.
    View PubMed
  362. Jaffe AS, TIMI research group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction - TIMI IIA results. J Am Med Assoc. 1988; 260:2849-58.
  363. Jaffe AS, Safdar S, Barzilai B, Semenkovich J, Saffitz J. Clinical Pathologic Conference: Carcinoma of the cervix with metastasis to the heart. Am J Med. 1988; 84:463-74.
  364. Eisenberg PR, Sobel BE, Jaffe AS. Characterization In Vivo of the fibrin specificity of activators of the fibrinolytic system. Circulation. 1988; 78:592-7.
    View PubMed
  365. Kennedy JW, Atkins JM, Goldstein S, Jaffe AS, McIntyre KM, Mueller HS, Paraskos JA, Weaver WD. Recent changes in management of acute myocardial infarction: Implications for Emergency Care Physicians. J Am Coll Cardiol. 1988; 11:446-9.
    View PubMed
  366. Eisenberg PR, Sherman LA, Perez J, Jaffe AS. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction. Thromb Res. 1987; 46:109-20.
    View PubMed
  367. Gessler CJ, Jaffe AS. Hemodynamic monitoring and pacing with one catheter: A pilot study. Cath and Cardiovasc Diag. 1987; 13:141-4.
  368. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BS, Jaffe As. Sustained fibrinolysis after administration of t-PA despite ist short half life in the circulation. Thromb and Hemostasis. 1987; 57:35-40.
  369. Tofler GH, Stone PH, Muller JE, Willich SN, Davis VKL, Poole WK, Strauss W, Willerson JT, Sobel BE, Jaffe AS, Robertson T, Passamani E, Braunwald E, MILIS study group. Effects of gender and race on prognosis after myocardial infarction: Adverse prognosis for women particularly black women. J Am Coll Cardiol. 1987; 9:473-82.
    View PubMed
  370. Cox DA, Stone PH, Muller JE, Parker C, Hartwell TD, Rutherford JD, Roberts R, Jaffe AS, Hackel DB, Passamani E, Robertson T, Sobel BE, Willerson JT, Braunwald E, MILIS study group. Prognostic implications of an early peak in plasma MB creatine kinase patients with acute myocardial infarction. J Am Coll Cardiol. 1987; 10:979-90.
    View PubMed
  371. Eisenberg PR, Sherman LA, Jaffe AS. Paradoxical elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis. JACC. 1987; 10:527-9.
    View PubMed
  372. Jaffe AS, Biello DR, Sobel BE, Geltman EM. Enhancement of metabolism of jeopardized myocardium by nifedipine. Intern J Cardiol. 1987; 15:77-89.
  373. Abendschein DR, Serota H, Plummer TH Jr, Amiraian K, Strauss AW, Sobel BE, Jaffe AS. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase. N J Lab Clin Med. 1987; 110:798-806.
  374. Carney RM, Rich M, teVelde A, Saini J, Clark K, Jaffe AS. Major depression disorder: A common psychiatric disorder in patients with coronary artery disease. Am J Cardiol. 1987; 60:1273-5.
    View PubMed
  375. Barzilai B, Gessler C, Perez JE, Schaab C, Jaffe AS. Significance of Doppler detected mitral regurgitation acute myocardial infarction. Am J Cardiol. 1987; 61:220-3.
  376. Jaffe AS, Sobel BE. Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls. JAMA. 1986 Jan 10; 255(2):237-9.
    View PubMed
  377. Turi ZG, Stone PH, Muller JE, Parker C, Rude RE, Raabe DE, Jaffe AS, Hartwell TD, Robertson TL, Braunwald E, MILIS Study Group. Implications for acute intervention of time of hospital arrival of patients with acute mycocardial infarction. Am J Cardiol. 1986; 58:203-9.
    View PubMed
  378. Genton R, Jaffe AS. Management of congestive heart failure in patients with acute myocardial infarction. JAMA. 1986; 256:2556-60.
    View PubMed
  379. Jaffe AS. The state of the art of myocardial infarction. Circulation (Suppl) -IV-123 1986; 74:IV-120.
  380. Jaffe AS. Cardiovascular Pharmacology I. Circulation ( 74 IV-7-IV-74 1986; Suppl).
  381. Eisenberg PR, Sherman L, Rich M, Schwartz D, Schechtman K, Geltman EM, Sobel BE, Jaffe AS. Importance of continued activation of thrombin reflected by fibrinopeptides A to the efficacy of thrombolysis. JACC. 1986; 7:1255-62.
    View PubMed
  382. Muller JE, Turi ZG, Stone PH, Rude RE, Raabe DS, Jaffe AS, Gold HK, Gustafson N, Poole WK, Passamani E, Smith TW, Braunwald E, MILIS Study Group. Digoxin therapy and mortality following myocardial infarction: Experience in the MILIS study. N Eng J Med. 1986; 314:265-71.
  383. Croft HC, Rude RE, Gustafson N, Stone PH, Poole WK, Roberts R, Strauss HW, Raabe DS, Thomas LJ, Jaffe AS, Muller J, Hoagland P, Sobel BE, Passamani ER, Braunwald E, Willerson JT, MILIS Study Group. Abrupt beta-blockade withdrawal in patients with acute myocardial infarction. Effects on infarct size, left ventricular function, and hospital course. Circulation. 1986; 73:1281-90.
    View PubMed
  384. Wheelan K, Mukharji J, Rude RE, Poole WK, Gustafson N, Thomas LJ, Strauss HW, Jaffe AS, Muller JE, Roberts R, Croft CH, Passamani E, Willerson JT, MILIS Study Group. Sudden death and its relationship to QT interval prolongation following acute myocardial infarction (2-year follow-up). Am J Cardiol. 1986; 57:745-50.
    View PubMed
  385. Stone PH, Turi ZG, Muller JE, Parker C, Hartwell T, Rutherford JD, Jaffe AS, Raabe DS, Passamani ER, Willerson JT, Sobel BE, Robertson TL, Braunwald E, MILIS study group. Prognostic significance of the exercise treadmill test performance six months after myocardial infarction. J Am Coll Cardiol. 1986; 8:1007-17.
    View PubMed
  386. Jaffe AS, Serota H, Grace A, Sobel BE. Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. Circulation. 1986; 74:105-9.
    View PubMed
  387. Spadaro JJ, Ludbrook PA, Tiefenbrunn AJ, Kurnik PB, Jaffe AS. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cath and Cardiovasc Dis. 1986; 12:230-4.
  388. Jaffe AS, Montgomery WH, Donegan J, McIntyre KM, et al. 1985 National Conference on Standards and Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care. JAMA. 1986; 255:2843-989.
  389. Pierce GF, Eds, Chan KM, Ladenson JH, Discussant, Jaffe AS. Increased creatine kinase MB isoenzyme in the absence of acute myocardial infarction. Clin Chemistry group. 1986; 32:2044-51.
  390. Jaffe AS, MILIS study group. Hyaluronidase therapy for acute myocardial infarction: Results of a randomized, blinded, multicenter trial. Am J Cardiol. 1986; 57:1236-43.
    View PubMed
  391. Turi ZG, Rutherford JD, Roberts R, Muller JE, Jaffe AS, Rude RE, Parker C, Raabe DS, Stone PH, Hartwell TD, et al. Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (A MILIS Study). Am J Cardiol. 1985 Jun 1; 55(13 Pt 1):1463-8.
    View PubMed
  392. Jaffe AS, TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial - Phase I findings N Engl J Med. 1985; 312:932-6.
    View PubMed
  393. Lamas GA, Muller JE, Turi ZG, Stone PH, Rutherford JD, Jaffe AS, Raabe DS, Rude RE, Mark DB, Califf RM, Gold HK, Robertson T, Passamani ER, Braunwald E, MILIS study group. A simplified method to predict the occurence of complete heart block during acute myocardial infarction Am J Cardiol. 1985; 57:1213-9.
  394. Eisenberg PR, Lee RG, Biello DR, Geltman EM, Jaffe AS. Chest pain after nontransmural infarction: The absence of remediable coronary vasospasm. Am Heart J. 1985; 11:515-31.
  395. Semenkovich CF, Jaffe AS. Adverse effects due to morphine sulfate: A challenge to previous clinical doctrine Am J Med. 1985; 79:325-30.
    View PubMed
  396. Jansen DE, Corbett JR, Lewis SE, Wolfe CL, Gabliani G, Filipchuk N, Redish G, Parkey RW, Buja M, Jaffe AS, Sobel BS, Willerson JT. Measurement of myocardial infarct size: A comparison of single photon emission computed tomography with pyrophosphate and serial CK-MB measurements Circulation. 1985; 72:237-333.
    View PubMed
  397. Eisenberg PE, Sherman LA, Schechtman K, Sobel BE, Jaffe AS. Fibrinopeptide A: A marker of acute coronary thrombosis Circulation. 1985; 71:912-8.
    View PubMed
  398. Jaffe AS, Spadaro JJ, Schechtman K, Robert R, Geltman EM, Sobel BE. Increased congestive heart failure after infarction of modest extent in patients with diabetes mellitus. Am Heart J. 1984; 108:31-7.
    View PubMed
  399. Shafer KE, Santoro SA, Sobel BE, Jaffe AS. Monitoring activity of fibrinolytic therapy: A therapeutic challenge. Am J Med. 1984; 75:879-86.
  400. Hackel DB, Reimer KA, Ideker RE, Mikat EM, Hartwell TD, Parker CB, Braunwald EB, Gold HK, Jaffe AS, Raabe DS, Rude RE, Sobel BE, Stone PH, Buja M, Muller JE, Roberts R, MILIS Study Group. Comparison of enzymatic, anatomic estimates of myocardial infarct in man. Circulation. 1984; 70:824-35.
    View PubMed
  401. Sedlis S, Saffitz J, Schwob V, Jaffe AS. Cardiac amyloidosis simulating hypertrophic myopathy. Am J Cardiol. 1984; 53:969-70.
    View PubMed
  402. Jaffe AS, Garfinkel BT, Ritter CS, Sobel BE. Plasma, MB creatine kinase after vigorous exercise in professional athletes Am J Cardiol. 1984; 53:856-8.
    View PubMed
  403. Mukharji J, Rude RE, Poole KW, Thomas LJ, Strauss HW, Jaffe AS, Muller JE, Roberts R, Raabe DS, Croft CH, Passamani E, Braunwald E, Willerson JT the MILIS Study Group. Late sudden death following acute myocardial infarction: Multivariate analysis of risk factors Am J Cardiol. 1984; 54:31-6.
    View PubMed
  404. Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactural increases in creatine kinase isoenzymes in patients with renal failure J Lab Clin Med. 1984; 104:193-202.
    View PubMed
  405. Eisenberg PR, Jaffe AS, Schuster DP. Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically-ill patients Crit Care Med. 1984; 12:549-52.
    View PubMed
  406. Roberts R, Croft C, Gold HK, Tyler DH, Jaffe AS, Muller JE, Mullin SM, Parker C, Passamani ER, Poole WK, Raabe DS, Rude RE, Stone PH, Turi G, Sobel BE, Willerson JT, Braunwald E, MILIS Study Group. Effect of propranolol on myocardial infarct size in a randomized, blinded, multicenter trial N Engl J Med. 1984; 311:218-25.
    View PubMed
  407. Sobel BE, Geltman EM, Tiefenbrunn AJ, Jaffe AS, Spadaro JJ, Ter-Pogossian MM, Collen D, Ludbrook PA. Improved regional myocardial metabolism after coronary thrombolysis iwth tissue-type plasminogen activator (t-PA) or streptokinase Circulation. 1984; 69:983-9.
    View PubMed
  408. Jaffe AS, Lee R, Perez J, Geltman EM, Wilner G, Sobel BE. Lack of elevation of platelet factor IV in plasma from patient with myocardial infarction J Am Coll Cardiol. 1984; 4:653-9.
    View PubMed
  409. Rosenblum AM, Ludbrook PA, Jaffe AS. Significance of elevated MB creatine kinase in patients after cardiac catheterization. Cardiac Catheter Diagn. 1984; 10:547-52.
  410. Stone PH, Muller JE, Turi ZG, Geltman E, Jaffe AS, Braunwald E. Efficacy of nifedipine therapy in patients with refractory angina pectoris: Significance of the presence of coronary vasospasm Am Heart J. 1983; 106:644-52.
    View PubMed
  411. Jaffe AS, Geltman EM, Tiefenbrunn AJ, Ambos HD, Strauss H, Sobel BE, Roberts R. Reduction in infarct size in patient with inferior infarction with intravenous nitroglycerin. A randomized prospective study. Br Heart J. 1983; 49:452-69.
    View PubMed
  412. Billadello JJ, Smith JL, Ludbrook PA, Tiefenbrunn AJ, Jaffe AS, Sobel BE, Geltman EM. The implications of "Reciprocal" ST segment depression associated with acute myocardial infarction identified by positron tomography J Am Coll Cardiol. 1983; 2:616-24.
    View PubMed
  413. Klahr S, Jaffe AS, McKeel T. Cyanotic Feet and Renal Failure in a 67-year-old man Am J Med. 1983; 75:509-17.
  414. Stone PH, Muller JE, Turi ZG, Geltman E, Jaffe AS, Braunwald E. Efficacy of nifedipine therapy in patients with refractory angina pectroris: Significance of the presence of coronary vasospasm. Arq Bras Cardiol. 1983; 41:469-76.
    View PubMed
  415. Gutierrez FR, McKnight RC, Jaffe AS, Ludbrook PA, Biello D, Weldon CS. Double porcine valve replacement in carcinoid heart disease: A case report. Chest. 1982; 181:101.
    View PubMed
  416. Jaffe AS, Robert R. Use of intravenous nitroglycerin in cardiovascular disease. Pharmacotherapy. 1982; 2(5):273-8.
    View PubMed
  417. Clark KW, Geltman EM, Miller JP, Moore P, Madden KA, Thomas JJ, Hartwell TD, Jaffe AS, Rabbe DS, Stone PH, Gold HK, Rude RE, the MILIS Study Group. Reproducibility of dysrhythmia findings by a centralized laboratory within a major multicenter trial. 1982 Proceeding of Computers in Cardiology, Seattle, Washington. 1982.
  418. Jaffe AS, Geltman EM, Rodey GE, Uitto J. Mitral valve prolapse:A consistent manifestation of type IV Ehlers-Danlos Syndrome (the pathogenic role of abnormal type III collagen synthesis). Circulation. 1981; 64:121.
    View PubMed
  419. Kornfeld S, Hruska K, Berger N, Jaffe AS, Shields H, DeSchriver K. Gastric outlet obstruction in patients with multiple myeloma. Am J Med. 1980; 68:141-48.
  420. Jaffe AS, Klein MS, Patel BR, Siegel BA, Roberts R. Abnormal technetium-99m pyrophosphate images in unstable angina: Ischemia versus infarction? Am J Cardiol. 1979; 44:1035.
    View PubMed
  421. Ahumada GG, Karlsberg RP, Jaffe AS, Ambos HD, Sobel BE, Roberts R. Reduction of early ventricular arrhythmias by acebutolol in patients with acute myocardial infarction Br Heart J. 1979; 41:654.
    View PubMed
  422. Srebro R, Jaffe AS. The origin of dark noise in foveal vision. J Optical Soc Am. 1968; 58:1313.